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ABSTRACT 
Objective: Chemometric assisted spectrophotometry, and HPLC methods have been developed for the simultaneous determination of phenylephrine 
hydrochloride (PEPH), paracetamol (PCM), guaifenesin (GNF), chlorpheniramine maleate (CPM) and bromhexine hydrochloride (BRM).  
Methods: The chromatographic separation was carried out on a Phenomenex RPC18 column. An isocratic elution was carried out with the mobile 
phase comprising methanol, acetonitrile and 10 mM phosphate buffer (pH 3) in the ratio of 27.5:22.5:50 respectively at a wavelength of 218 nm. 
Two chemometric methods i.e. principal component regression (PCR) method and partial least squares (PLS) method were also developed to 
quantify each drug in the mixture using the information included in the UV absorption spectra of appropriate solutions in the range 210–320 nm 
with the intervals of 2 nm at 51 wavelengths.  
Results: The three methods were successfully applied to a tablet formulation and the results were compared statistically by applying ANOVA, which 
showed no significant difference among the three methods. The methods were applied to the dissolution study of the five components in tablet 
formulation and the percentage release of all the five components was found to be greater than 85% within 45 min by all the three methods. 
Conclusion: Thus, the proposed methods, i.e., PLS, PCR and HPLC, were found to be suitable and can be successfully used for the determination of 
the PEPH, PCM, GNF, CPM and BRM in pharmaceutical tablet formulation as well as for dissolution study. 
Keywords: HPLC, UV, Chemometrics, Cough-cold tablets, Dissolution. 
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INTRODUCTION 
Among the medicines used for the treatment of cough-cold, various 
formulations consist of combinations of more than two or three 
drugs (multicomponent system). The analysis of such multi 
component formulations becomes difficult by conventional 
analytical techniques like UV spectrophotometry. However, since 
last few years, the chemometric calibration techniques, such as 
inverse least squares (ILS), classical least squares (CLS), principal 
component regression (PCR) and partial least squares (PLS), have 
widely been applied to the spectrophotometric resolution of such 
multi component formulations without preliminary separation. PLS 
and PCR are especially suited for multi component analysis, 
particularly for mixtures with highly overlapped spectra. Although 
the HPLC method provides a suitable method for the analysis, but it 
requires many trials, expensive and high purity solvents and proves 
to be more time consuming.  
The mixture of phenylephrine hydrochloride (PEPH), paracetamol 
(PCM), guaifenesin (GNF), chlorpheniramine maleate (CPM) and 
bromhexine hydrochloride (BRM) is the one most widely used the 
combination for cough and cold therapy. It is mainly used in diseases 
accompanied by cough, pain and fever, common cold and other viral 
infections and also used as an analgesic, antipyretic, decongestant, 
antihistaminic and antitussive. Phenylephrine hydrochloride (PEPH) 
(fig. 1), (R)-3-[-1-hydroxy-2-(methylamino)ethyl]phenol, has a 
decongestant property; paracetamol (PCM) (fig. 1), N-(4-
hydroxyphenyl)acetamide, is a mild analgesic; guaifenesin (GNF) 
(fig. 1), (RS)-3-(2-methoxyphenoxy)propane-1,2-diol, is used as 
an expectorant; chlorpheniramine maleate (CPM) (fig. 1), 3-(4-
chlorophenyl)-N,N-dimethyl-3-pyridin-2-yl-propan-1-amine, is used 
as an antiallergic and bromhexine hydrochloride (BRM) (fig. 1), 2,4-




Fig. 1: Structure of PEPH, PCM, GNF, CPM and BRM 
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Several analytical methods are available for the determination of 
PEPH, PCM, GNF, CPM and BRM in various combinations as cough 
and cold formulations, amongst which some are: high performance 
liquid chromatography (HPLC) methods [1-8], atomic emission 
spectrometry [9], mixed ion-pair liquid chromatography [10], liquid 
chromatography–tandem mass spectrometry [11], non-aqueous 
capillary electrophoresis [12], gas chromatography [13] and 
multivariate analytical methods [14, 15]. Chemometric assisted 
spectrophotometric methods and HPLC method for the combination 
under study has not been reported yet.  
The aim of this study was to investigate the ability of PLS and PCR 
methods for simultaneous quantification of the five components. The 
five drug combination (formulation) under study has a wide 
difference in the weight of components in its tablet formulation, 
wide differences in the absorptivity of the five components and high 
UV overlap thus making it a challenging task to develop the 
simultaneous spectrophotometric method. So UV method in 
assistance with chemometric methods like PLS and PCR has been 
developed for simultaneous quantification of the five components. 
An isocratic HPLC method has also been developed and the results of 
the chemometric methods have been statistically compared with 
HPLC method. The proposed methods are simple, accurate, reduce 
the duration of analysis and are suitable for routine determination of 
the five components in the commercial formulation.  
MATERIALS AND METHODS 
Instrumentation 
Chromatography was performed on Shimadzu (Shimadzu 
Corporation, Kyoto, Japan) chromatographic system equipped with 
Shimadzu LC-20AD and Shimadzu PDA-M20A Diode Array Detector. 
Samples were injected through a Rheodyne 7725 injector valve with 
fixed loop at 20 μl. Data acquisition and integration were performed 
using LC Solution Software (Shimadzu Corporation, Kyoto, Japan). 
Separation and quantification were made on a Phenomenex RPC18 
column (5 µm × 250 mm × 4.6 mm i.d.).  
Shimadzu UV-1700 double beam spectrophotometer connected to a 
computer with the Shimadzu UV Probe 2.10 software was used for 
all the spectrophotometric measurements. The absorbance spectra 
of the reference and test solutions were measured in 1 cm quartz 
cells over the range of 200-400 nm. PLS and PCR analyses were 
carried out by using Unscrambler software version 2013. The 
dissolution was performed on Veego VDA6DR dissolution apparatus. 
Materials and reagents 
Bromhexine hydrochloride, paracetamol, phenylephrine hydro-
chloride, guaifenesin and chlorpheniramine maleate were provided by 
Ethicare Pharmaceuticals and Alembic Pharmaceuticals (Vadodara, 
India), as gift samples.  
HPLC grade methanol and acetonitrile (Spectrochem), potassium 
dihydrogen phosphate (AR grade, Loba Chem), phosphoric acid (AR 
grade, Loba Chem) and triethylamine (HPLC grade, Spectrochem) 
were used for HPLC analysis. AR grade methanol (Spectrochem) was 
used for spectrophotometry. AR grade hydrochloric acid (Merck) 
was used for dissolution. A commercial formulation of Intas 
Pharmaceutical (Kuff Q tablet) was used for the study. Each tablet 
contains paracetamol (450 mg), phenylephrine hydrochloride (10 
mg), guaifenesin (100 mg), chlorpheniramine maleate (2 mg) and 
bromhexine hydrochloride (8 mg). 
Experimental conditions 
For HPLC, phosphate buffer (0.01 M) was prepared by dissolving 
1.36 g of anhydrous potassium orthophosphate (KH2PO4) in 1 L of 
previously filtered double distilled water, 0.1% of triethylamine was 
added to it and the pH was adjusted to 3.0 using phosphoric acid. 
The elution was carried out with a mobile phase composed of the 
mixture of methanol, acetonitrile and 0.01 M phosphate buffer (pH 
3) in the ratio of 27.5:22.5:50. All determinations were performed at 
ambient temperature. The flow rate was 1 ml/min. The injection 
volume was 20 µl and detection wavelength was 218 nm.  
For UV chemometrics, the UV absorption spectra of appropriate 
solutions (in methanol) were recorded in the wavelength range 200-
400 nm. The range of 210-320 nm with intervals of 2 nm (Δλ = 2 nm) 
was selected for PLS and PCR model. 
The dissolution was carried out by USP paddle method. The 
dissolution media comprised of 0.01N HCl prepared in single 
distilled water. The conditions for dissolution were 50 rpm at 37 °C 
temperature for the duration of 90 min.  
Standard solutions  
For HPLC, standard solutions of each of PEPH, PCM, GNF, CPM and 
BRM were prepared in the mobile phase within the concentration 
range of 5-20 µg/ml PEPH, 225-900 µg/ml PCM, 50-200 µg/ml GNF, 
1-4 µg/ml CPM and 4-16 µg/ml BRM. The diluted standard solutions 
with varying concentrations were analysed by HPLC (in triplicate). 
  
Table 1: Training set 
Mixture PEPH GNF CPM PCM BRM 
1 15 1 5 7 12 
2 15 5 8 11 2 
3 15 12 1 3 9 
4 1 15 5 7 12 
5 11 15 1 3 9 
6 1 5 15 7 12 
7 7 12 15 1 6 
8 11 1 15 3 9 
9 1 5 8 15 12 
10 3 8 12 15 2 
11 11 1 5 15 9 
12 7 12 1 3 15 
13 3 5 5 3 6 
14 7 8 8 7 9 
15 1 5 5 3 6 
16 1 8 8 7 9 
17 3 1 5 3 6 
18 7 1 8 7 9 
19 7 8 1 7 9 
20 3 5 5 1 6 
21 3 5 5 3 1 
22 7 8 8 7 1 
23 11 12 8 7 9 
24 7 8 12 11 9 
25 7 8 8 11 12 
26 11 8 8 7 12 
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Table 2: Validation set 
Mixture PEPH GNF CPM PCM BRM 
1 3 5 3 10 6 
2 3 5 3 15 6 
3 3 5 3 6 12 
4 3 5 3 6 15 
5 7 8 7 15 9 
6 4 4 4 9 4 
7 7 8 7 6 6 
8 7 8 3 6 9 
9 7 3 15 8 9 
10 15 3 5 4 4 
11 3 15 11 6 4 
12 11 4 4 8 6 
13 3 11 4 6 6 
14 3 12 4 8 6 
 
 
Fig. 2: HPLC chromatogram of sample solution containing 10 ppm PEPH, 450 ppm PCM, 100 ppm GNF, 2 ppm CPM and 8 ppm BRM 
 
For UV chemometrics methods, the standard solutions of each of 
PEPH, PCM, GNF, CPM and BRM were prepared in methanol. A training 
set of 26 synthetic mixtures (table 1) and validation set of 15 mixtures 
(table 2) with different concentrations of each compound were 
prepared in the range of 3-15 µg/ml PEPH, 4-15 µg/ml PCM, 3-15 
µg/ml GNF, 5-15 µg/ml CPM and 4-15 µg/ml BRM. The UV absorption 
spectra were recorded over the range 200-400 nm. 
Analysis of tablet formulation 
For HPLC, twenty commercial tablets were accurately weighed and 
powdered in the mortar. An amount of powder equivalent to 45 mg of 
PCM, 0.8 mg of BRM, 10 mg GNF, 1 mg PEPH and 0.2 mg of CPM was 
taken in 25 ml of volumetric flask sufficient mobile phase was added and 
sonicated for 10 min. The volume was then made up to the mark with 
the mobile phase. This solution was filtered through Whatman filter 
paper (No. 42) so as to remove undissolved tablet excipients. From this 
solution, 2.5 ml aliquot was taken and further diluted to 10 ml with the 
mobile phase. Chromatogram of the sample solution is shown in fig. 2. 
For UV chemo metrics, twenty commercial tablets were accurately 
weighed and powdered. An amount of powder equivalent to 45 mg 
of PCM, 0.8 mg of BRM, 10 mg GNF, 1 mg PEPH and 0.2 mg of CPM 
was taken in 25 ml volumetric flask. To this powder, standard 
addition of 20 mg PEPH, 20 mg CPM and 20 mg BRM was done, 
owing to their too much low quantity (below LOD of the UV range) in 
the formulation. This powder mixture was dissolved in sufficient 
quantity of methanol and sonicated for 10 min. The volume was then 
made up to the mark with the methanol. This solution was filtered 
through Whatman filter paper (No. 42) so as to remove undissolved 
tablet excipients. From this filtered solution, 0.1 ml aliquot was taken 
and was further diluted to 10 ml with methanol. 
Dissolution study 
The dissolution media was 0.01N HCl, which is the official media 
reported for the dissolution of PCM and CPM [16]. The dissolution 
study was performed for 90 min and the sampling was done at 
different time intervals of 5, 10, 15, 30, 45, 60 and 90 min. 5 ml of the 
aliquot was withdrawn from the dissolution vessel at a specific time 
point. For HPLC analysis, the sample (aliquot) was filtered through 
0.2µ membrane filter and injected into the HPLC. For chemometrics 
analysis, 0.1 ml aliquot was taken in a 10 ml volumetric flask 
followed by the standard addition of 1 ml (10µg/ml) of PEPH, CPM 
and BRM each. The solution was made up to the mark with methanol 
and analysed by UV spectrophotometer.  
RESULTS AND DISCUSSION 
There are various HPLC [1-8] and UV-chemometrics methods [14, 15] 
available in the literature for the simultaneous estimation of various 
cough-cold combinations like for the combination of acetaminophen, 
phenylephrine, chlorpheniramine with cyano column [1], pseudo-
ephedrine, pheniramine, guaifenesin, pyrilamine, chlorpheniramine 
and dextromethorphan [2], pseudoephedrine hydrochloride, dextro-
meth orphan hydrobromide, chlorpheniramine maleate and 
paracetamol [3], but there is no method reported for the combination 
under study (which is one of the most commonly used formulation). 
The importance and hence the challenge for this particular 
combination was that the APIs present in the combination have a wide 
difference in their weight ratio (i.e. PEPH: PCM: GNF: CPM: BRM in 
ratio of 5:225:50:1:4 respectively) which makes them difficult to 
analyse by UV owing to the different detection limits and the different 
linearity ranges of different components. Moreover, the present 
method offers the advantage of analysing the five components by a 
simple UV technique avoiding the difficulties and lengthy procedures 
of the HPLC method.  
Optimisation of HPLC method 
To optimize the chromatographic conditions, the effect of various 
chromatographic factors such as: type of buffer (phosphate buffer and 
formate buffer), pH of buffer (pH 3 to 7), concentration of buffer (10 
mM and 25 mM); organic solvent (methanol and acetonitrile); 
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composition of mobile phase; flow rate (0.8 to 1.2 ml/min) and 
temperature (25 °C and 40 °C) were studied. Good peak shape and 
good resolution were observed in phosphate buffer as compared to 
formate buffer. Acidic pH favoured good peak shapes for all the five 
drugs. Various combinations of organic and buffer were tried amongst 
which a ternary mixture of acetonitrile, methanol and buffer gave the 
best results in terms of peak shape, resolution and other system 
suitability parameters. The peak shape got a little distorted with high 
concentrations (25 mM) of the buffer, so 10 mM buffer was used. 
Temperature and flow rate had no significant effects. Hence, with 
respect to all these trials, 10 mM phosphate buffer at pH 3 in 
combination with suitable organic phase (mixture of methanol and 
acetonitrile) in a ratio of buffer: acetonitrile: methanol as 50:27.5:22.5, 
at flow rate of 1 ml/min and ambient temperature were selected as the 
chromatographic conditions.  
The developed HPLC method was applied to the simultaneous 
determination PEPH, PCM, GNF, CPM, and BRM in tablet formulation 
as well as for the dissolution study of the tablet. A satisfactory 
separation was obtained with an isocratic elution. Quantitation was 
achieved based on peak area with UV detection at 218 nm for 20 
min. The average retention time in min±standard deviation (for six 
replicates) for PEPH, PCM, GNF, CPM and BRM was found to be 
2.63±0.01, 3.23±0.005, 4.59±0.01, 6.07±0.048, 12.6±0.13 respectively.  
HPLC method validation 
The HPLC method was validated for linearity, accuracy, precision, 
and limit of detection, limit of quantitation, specificity and 
robustness by the ICH guidelines [17]. 
Linearity 
The linearity of the HPLC detector response for determination of 
PEPH, PCM, GNF, CPM and BRM was evaluated by analysing a series 
of different concentrations of each compound. The calibration range 
was established with respect to the practical range necessary, 
according to the marketed formulation, to give accurate, precise and 
linear results. In this study, seven concentrations were chosen, in the 
range of 5-20 µg/ml PEPH, 225-900 µg/ml PCM, 50-200 µg/ml GNF, 
1-4 µg/ml CPM and 4-16 µg/ml BRM. Characteristic parameters for 
regression equations by the HPLC method are given in table 3. 
Precision 
For evaluation of the precision estimates, repeatability and 
intermediate precision was performed at three concentration levels 
for each compound. The peak areas of all five drugs were calculated 
for each trial. The experiment was repeated three times in a day for 
intra-day precision and on three different days for inter-day 
precision. The average % RSD (relative standard deviation) of intra-
day measurements for determination of PEPH, PCM, GNF, CPM and 
BRM are given in table 3. 
Accuracy 
The accuracy was performed by the standard addition method. Known 
amounts of standard APIs were added to a known concentration of the 
commercial tablet formulation at three levels of standard edition 
(80%, 100%, and 120%). The resulting mixtures were analysed and 
the results obtained were compared with the expected results.  
The excellent recoveries of standard addition method (table 3) for 
HPLC suggested the good accuracy of the proposed method. The 
influence of the commonly used tablet excipients was investigated 
before the determination of the studied compounds in the tablet. No 
interference could be observed with the proposed method.  
Detection and quantitation limits 
For determining the limit of detection (LOD) and limit of quantitation 
(LOQ), the approach based on the standard deviation (S. D.) of the y-
intercept and the slope was used and the values obtained are given in 
table 3 which shows the sensitivity of the method. 
 
Table 3: Characteristic parameters of the calibration equations for the proposed HPLC method for simultaneous determination of PEPH, 
PCM, GNF, CPM and BRM 
Parameters PEPH PCM GNF CPM BRM 
Calibration range(µg/ml) 5-20 225-900 50-200 1-4 4-16 
Detection limit (µg/ml) 0.02 1.34 0.087 0.002 0.05 
Quantitation limit (µg/ml) 0.074 4.062 0.265 0.008 0.16 
Regression equation y=mx+c 
Slope (m)±SD 5722.51±0.91 25122.09±0.81 6312.33±0.96 15356.89±1.01 11121.77±0.39 
Intercept (c)±SD 2353.41±0.62 9002.63±0.49 1611.86±0.74 1421.61±0.49 113.76±0.98 
Regression coefficient (r2) 0.9994 0.9982 0.9991 0.9992 0.9993 
Accuracy (% recovery±SD)# 
80% 97.57±1.16 99.6±0.82 99.16±1.25 99.91±0.68 99.18±1.07 
100% 98.46±0.94 100.99±1.24 101.32±1.15 101.39±1.15 98.74±0.94 
120% 99.65±1.10 100.37±1.01 99.69±0.67 99.66±0.3 99.02±0.6 
Precision  (%RSD)* 
Intraday 0.90 1.18 1.21 1.13 0.89 
Interday 1.72 1.58 1.80 1.91 1.70 
*Mean value of n=3 replicates for three concentrations; SD is the standard deviation, #Mean recovery of the concentrations at 80%, 100% and 120% 
level of standard addition for n=3 replicates 
 
Robustness 
Robustness study was performed by making variations in pH of 
the phosphate buffer by ±0.2 (2.8, 3, 3.2), change in flow rate by 
±0.1 (0.9 ml/min, 1.0 ml/min, 1.1 ml/min) and change in the 
composition of buffer solution by ±1% (49%, 50% and 51%) did 
not have significant effects on chromatographic resolution in the 
HPLC method.  
Solution stability 
The studied compound solutions prepared in the mobile phase 
exhibited no changes in HPLC or UV data for 24 h when kept at 
room temperature, and for two days when stored in the 
refrigerator (8-25 °C). No additional peak was found in the 
chromatogram which indicated the stability of the solutions. 
Specificity 
The method was found to be specific as the results were unaffected 
by the presence of the tablet excipients as shown in fig. 2.  
System suitability parameters 
Theoretical plates, symmetry factor and resolution for PEPH, PCM, 
GNF, CPM, and BRM in the sample solution were calculated for 
system suitability of the HPLC method. Satisfactory results were 
obtained as shown in table 4. 
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Table 4: System suitability parameters for the five components 
Parameters PEPH PCM GNF CPM BRM 
Retention Time 2.63±0.01 3.23±0.005 4.59±0.01 6.07±0.048 12.6±0.13 
Theoretical Plates 3600.81±1.23 3772.68±0.95 7847.76±1.71 7248.06±1.38 9194.40±1.54 
Symmetry factor 1.79±0.04 1.67±0.039 1.51±0.003 1.58±0.031 1.83±0.095 
Resolution -- 3.11±0.11 6.51±0.28 5.99±0.17 16.16±0.26 
Mean (for n=6 determinations)±standard deviation 
 
UV chemometrics methods (PLS, PCR) 
Fig. 3 shows the UV absorption spectra of PEPH, PCM, GNF, CPM, and 
BRM at their nominal concentrations. The simultaneous determination 
of PEPH, PCM, GNF, CPM, and BRM in tablet by conventional 
spectrophotometric methods is hindered by strong spectral overlap 
throughout the wavelength range and also the wide difference in the 
ratio of APIs in the formulation. PLS and/or PCR calibration methods 
are necessary for such determination due to the presence of this 
spectral interference.  
Various HPLC methods have been reported in the literature [14, 15] 
for a variety of combinations of drugs used as cough-cold formulations. 
But the present method consists of chemometrics assisted UV method 
wherein the chemo metric methods like PLS and PCR have been used 
to resolve the overlapped spectra of the five components under study 
as shown in fig. 3.  
 
 
Fig. 3: UV absorption spectra of PEPH, PCM, GNF, CPM and BRM 
each 10 µg/ml and synthetic mixture of all five drugs 
 
The quality of multi component analysis is dependent on the 
wavelength range and spectral mode used. In this work, the spectral 
resolution was assayed with absorbance spectra for PLS and PCR 
methods, measured at 2 nm intervals over the range 210–320 nm. 
Wavelengths less than 210 nm were rejected as they were not found 
to be of much significant contribution for determining the 
concentration of the five components. Wavelengths more than 320 
nm were not used because all the five drugs do not absorb in this 
region, so any absorbance values obtained at these wavelengths 
would have introduced a significant amount of noise in the 
calibration matrix, thereby decreasing the precision. 
The predicted concentrations of the components in each sample 
were compared with the actual concentrations in these training 
samples and the root mean square error of prediction (RMSEP) was 
calculated for each method. RMSEP value was used as a diagnostic 
test to examine the errors in predicting concentrations of the 
mixtures of the validation set. 
Due to the wide difference in the ratio of APIs in the marketed 
formulation (i.e. PEPH: PCM: GNF: CPM: BRM = 5: 225: 50: 1: 4), a 
standard addition of some components (i.e. PEPH, CPM and BRM) 
was required, to bring them at the proper the quantitation limit of 
UV range.  
For PCR and PLS methods, 26 calibration spectra were used for the 
selection of the optimum number of factors by using the cross-
validation technique. This allowed modelling of the system with the 
optimum amount of information and avoidance of over fitting or 
under fitting. The cross-validation procedure consists of 
systematically removing one of a group of training samples in turn 
and using only the remaining ones for the construction of latent 
factors and applied regression [16]. The model should have as low 
residual variance as possible i.e. explained variance should approach 
100%. For this, a number of principal components (in PCR) and the 
latent factors (in PLS) should be optimised.  
Validation of chemo metric methods 
RMSEP and PRESS value 
The predictive ability, i.e. the validation of PCR and PLS models, was 
thus assessed by the PRESS value, RMSEP value and residual values 
of actual concentration and predicted concentration (positive 
difference of actual and predicted values) [18]. The results are 
shown in table 5. A satisfactory value of the regression coefficient 
showed the good predictive ability of the chemometrics models. For 
the selected principal components (for PCR) and factors (for PLS), 
the concentration of each sample was then predicted and compared 
with known concentration (actual value) and the PRESS (prediction 
residual error sum of squares) value was calculated (equation 1) as 
the difference between the real and the calculated concentrations, 
squared and summed, over all references for each component. The 
RMSEP value (root mean square error of prediction) was calculated 
by using equation 2. The selected model was that with the fewest 
number of factors such that its RMSEP values were not significantly 
greater than that for the model, which yielded the lowest RMSEP. A 
plot of RMSEP values against number of components is shown in fig. 
4 which indicates that factor six and seven were optimum for the 
estimation of the principle ingredients by PLS and PCR. The RMSEP 
values are indicated in table 5.  
Accuracy 
The accuracy of the chemo metric methods was performed by the 
standard addition method at three levels (80%, 100%, and 120%). 
The resulting mixtures were analysed and the results obtained were 
compared with the true values as shown in shown in table 5. The 
influence of the commonly used tablet excipients was investigated 
before the determination of the studied compounds in the tablet. No 
interference could be observed with the proposed methods.  
Precision 
The precision of PLS and PCR method was performed at three 
concentration levels for each compound. The solutions were 
prepared and analysed three times in a day for intra-day precision 
and on three different days for inter-day precision. The average % 
RSD of intra-day and inter-day measurements for determination of 
PEPH, PCM, GNF, CPM and BRM are given in table 5. 
Solution stability 
The stability of the solutions prepared in methanol (for chemo 
metric study), exhibited no spectrophotometric changes for seven 
days in the refrigerator (8-25 °C). 
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Fig. 4: RMSEP plot of a calibration set prediction (using cross-validation) of PCR model (A) and PLS model (B) for PEPH, PCM, GNF, CPM and BRM 
 
Table 5: Characteristic parameters of the proposed PLS and PCR method for simultaneous determination of PEPH, PCM, GNF, CPM and BRM 
Parameters  PEPH PCM GNF CPM BRM 
RMSEP PLS 0.034 0.022 0.047 0.037 0.0047 
 PCR 0.019 0.019 0.017 0.0015 0.0081 
r2# PLS 0.9997 0.9994 0.9996 0.9997 0.9998 
 PCR 0.9997 0.9998 0.9998 0.9999 0.9996 
Regression 
Equation# 
PLS y = 0.991x+0.025 y = 1.004x-0.060 y = 0.994x+0.016 y = 0.995x+0.025 y = 1.006x-0.078 
PCR y = 0.999x-0.007 y = 0.998x-0.008 y = 1.005x-0.028 y = 0.993x+0.017 y = 0.996x+0.011 
Accuracy* Mean % Recovery±SD 
80% PLS 99.649±0.779 100.369±0.573 100.108±0.610 99.769±0.222 100.276±0.402 
 PCR 99.649±0.555 99.875±0.577 99.441±0.490 100.458±0.807 100.075±0.423 
100% PLS 100.368±0.827 99.782±0.641 99.653±0.267 100.421±0.562 99.829±1.139 
 PCR 99.621±0.777 100.165±0.340 100.376±0.857 100.825±0.724 100.442±0.797 
120% PLS 99.944±0.182 100.091±0.315 99.963±0.407 100.171±0.490 100.367±0.551 
 PCR 99.965±0.484 99.848±0.669 99.981±0.405 99.814±0.511 100.202±0.454 
Precision$ Mean % Recovery±SD 
Intraday PLS 99.67±0.59 99.33±1.16 98.88±0.77 99.59±0.56 99.36±0.61 
 PCR 99.61±0.41 99.02±0.77 98.96±0.74 99.61±0.61 99.89±0.98 
Interday PLS 99.67±0.85 98.93±1.45 99.66±1.11 101.18±0.72 99.59±1.39 
 PCR 99.31±0.79 99.26±1.53 100.65±0.89 101.71±0.76 99.31±1.14 
#r2 and regression equation for the predicted concentration versus true concentration plot, $ Mean value of three determinations for three 
concentrations, *Mean recovery of the predicted concentrations at 80%, 100% and 120% level of standard addition for n=3 replicates 
 
Analysis of tablet formulation 
The proposed PLS, PCR and HPLC methods were applied to the 
simultaneous determination of PEPH, PCM, GNF, CPM, and BRM in 
the commercial tablet as well as the dissolution of tablets. The 
determinations were made in six replicates. Satisfactory results 
were obtained for each compound in good agreement with the label 
claims (table 6). Results of the proposed PLS and PCR methods were 
also compared with those of the proposed HPLC method. Statistical 
comparison between the results of the two chemometric methods 
with respect to HPLC method was performed with regards to the 
recovery results using Student’s t-test and F-ratio at 95% confidence 
level. There was no significant difference between the results as 
stated in table 7. The three methods were also applied to the study 
dissolution of the tablet formulation, and the dissolution profiles are 
shown in fig. 5. From the dissolution data, it was found that the 
percentage release of all the five drugs was above 85% in 60 min. 
Thus the proposed methods, i.e., PLS, PCR and HPLC, were found to 
be suitable and can be successfully used for the determination of the 
PEPH, PCM, GNF, CPM and BRM in pharmaceutical tablet 
formulation as well as for the dissolution study. 
 
Table 6: Determination of PEPH, PCM, GNF, CPM and BRM in commercial tablet using the proposed methods 
Commercial tablet PLS PCR HPLC 
PEPH 99.07±0.99 98.7±1.22 99.48±0.54 
PCM 100.63±0.98 99.34±0.71 98.35±1.32 
GNF 99.51±0.89 100.17±0.65 101.32±1.23 
CPM 98.8±1.19 99.4±0.71 98.98±0.76 
BRM 98.9±1.20 98.48±1.31 98.66±0.68 
mean±SD, percentage recovery from the label claim amount 
 
Table 7: Statistical evaluation for the three analytical methods 
 Methods PEPH PCM GNF CPM BRM 
**F-value PLS 0.18 3.76 0.25 3.24 0.89 
 PCR 0.13 1.53 0.77 3.25 0.60 
**t-value PLS 0.43 1.94 0.50 1.80 0.95 
 PCR 0.35 0.12 0.87 1.27 0.78 
**Theoretical values for F and t are 4.96 and 2.23 respectively. 
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Fig. 5: Dissolution profiles of PEPH, PCM, GNF, CPM and BRM analysed by HPLC, PLS and PCR method showing the percentage release of 
the five components at different time points (5, 10, 15, 30, 45, 60 and 90 min) for n=6 replicates 
CONCLUSION 
The chemometric assisted spectrophotometric methods (PLS and 
PCR) and RPHPLC method have been proposed and successfully 
applied for the simultaneous determination of PEPH, PCM, GNF, 
CPM, and BRM in their commercial tablet formulation. The assay and 
dissolution results obtained by chemometric methods were found to 
be in good coincidence with that of HPLC method. The HPLC method 
is more specific than the chemometric assisted spectrophotometric 
methods, but it needs expensive equipment and materials such as 
columns and HPLC grade solvents. Chemometric methods are less 
expensive and do not require sophisticated instrumentation and any 
prior separation step. This can be considered as an advantage of the 
chemometric techniques over HPLC. The proposed methods, i.e., 
PLS, PCR and HPLC, were found to be suitable and can be 
successfully used for the determination of the PEPH, PCM, GNF, CPM 
and BRM in pharmaceutical tablet formulation as well as for the 
dissolution study. 
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